Cardiomyopathy
Comparison of Survival Among Patients With Connective Tissue Disease and Cardiomyopathy (Systemic Sclerosis, Systemic Lupus Erythematosus, and Undifferentiated Disease)

https://doi.org/10.1016/j.amjcard.2007.03.054Get rights and content

Connective tissue disease (CTD) encompasses several disease or abnormal states characterized by inflammatory or degenerative changes in connective tissue. These disorders affect many organs, including the heart. However, the long-term survival of patients with cardiomyopathy and CTD is not known. The prognostic implications of different categories of CTD were studied in patients with cardiomyopathy. One thousand seven hundred patients with initially unexplained cardiomyopathy who underwent endomyocardial biopsy from 1983 to 2003 at The Johns Hopkins Hospital were evaluated. Seventy-one subjects were diagnosed with CTD. This cohort was followed for an average of 5.1 years. Among the different disorder categories within CTD, there was a significantly lower survival rate for subjects with undifferentiated CTD (adjusted hazard ratio for death 2.39, 95% confidence interval 1.27 to 4.48, p = 0.007) and a trend toward decreased survival in patients with systemic sclerosis (adjusted hazard ratio for death 1.75, 95% confidence interval 0.93 to 3.29, p = 0.081) compared with those with idiopathic dilated cardiomyopathy (DCM). No significant survival difference was observed between systemic lupus erythematosus and idiopathic DCM (p = 0.41). The long-term outcomes of subjects with CTD and myocarditis were not statistically different from the outcomes of those with CTD and no myocarditis (p = 0.71). In conclusion, the diagnosis of cardiomyopathy and either undifferentiated CTD or systemic sclerosis appears to be a poor prognostic indicator compared with the diagnosis of idiopathic DCM. Patients with systemic lupus erythematosus and cardiomyopathy have a similar prognosis to those with idiopathic DCM. Finally, the presence of myocarditis does not alter the survival of patients with CTD and cardiomyopathy.

Section snippets

Selection of patients

We evaluated 1,700 patients with unexplained cardiomyopathy who underwent endomyocardial biopsy (EMB) from 1983 to 2003 at The Johns Hopkins Hospital. Most of these patients were referred to us by other physicians, and some common causes of heart failure, such as ischemic heart disease, hypertension, and valvular heart disease, were likely underrepresented. At the time of referral to The Johns Hopkins Hospital for the initial evaluation, the causes of patients’ heart failure were unknown.

Clinical and hemodynamic characteristics of the study population

Specific diagnoses for all patients with CTD and cardiomyopathy are listed in Table 1. The 3 most common categories in descending order of frequency were undifferentiated CTD, SLE, and SS. The clinical and hemodynamic characteristics of patients with CTD and those with idiopathic DCM are listed in Table 2. Most patients with CTD were middle aged, white women, with a similar degree of hemodynamic compromise (Table 2). Patients with SLE and cardiomyopathy had significantly higher rates of

Discussion

Our study examined the prognosis of patients with cardiomyopathy and CTD. We explored, for the first time, long-term survival in patients with cardiomyopathy associated with SS, SLE, undifferentiated CTD, or CTD and myocarditis. The finding of a poor outcome in patients with SS relative to those with idiopathic DCM is consistent with previous reports showing a grave prognosis in subjects with SS and clinically significant cardiac involvement12, 17 and may indicate that patients with SS and

References (22)

  • V.J. Alcocer et al.

    Immunologic studies in patients with Takayasu’s arteritisIII. Immunoregulatory changes

    Clin Exp Rheumatol

    (1989)
  • Cited by (0)

    View full text